5-180618911-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_182925.5(FLT4):c.2860C>T(p.Pro954Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0057 in 1,585,876 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 32 hom. )
Consequence
FLT4
NM_182925.5 missense
NM_182925.5 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: 3.79
Publications
22 publications found
Genes affected
FLT4 (HGNC:3767): (fms related receptor tyrosine kinase 4) This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
FLT4 Gene-Disease associations (from GenCC):
- lymphatic malformation 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- capillary infantile hemangiomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- congenital heart defects, multiple types, 7Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- lymphatic malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006272793).
BP6
Variant 5-180618911-G-A is Benign according to our data. Variant chr5-180618911-G-A is described in ClinVar as Benign. ClinVar VariationId is 16264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00346 (527/152298) while in subpopulation NFE AF = 0.00619 (421/68010). AF 95% confidence interval is 0.0057. There are 4 homozygotes in GnomAd4. There are 225 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 527 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FLT4 | NM_182925.5 | c.2860C>T | p.Pro954Ser | missense_variant | Exon 21 of 30 | ENST00000261937.11 | NP_891555.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLT4 | ENST00000261937.11 | c.2860C>T | p.Pro954Ser | missense_variant | Exon 21 of 30 | 1 | NM_182925.5 | ENSP00000261937.6 |
Frequencies
GnomAD3 genomes AF: 0.00346 AC: 527AN: 152182Hom.: 4 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
527
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00354 AC: 681AN: 192522 AF XY: 0.00372 show subpopulations
GnomAD2 exomes
AF:
AC:
681
AN:
192522
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00594 AC: 8519AN: 1433578Hom.: 32 Cov.: 34 AF XY: 0.00597 AC XY: 4242AN XY: 710598 show subpopulations
GnomAD4 exome
AF:
AC:
8519
AN:
1433578
Hom.:
Cov.:
34
AF XY:
AC XY:
4242
AN XY:
710598
show subpopulations
African (AFR)
AF:
AC:
38
AN:
33134
American (AMR)
AF:
AC:
68
AN:
40938
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
25528
East Asian (EAS)
AF:
AC:
0
AN:
38434
South Asian (SAS)
AF:
AC:
304
AN:
82508
European-Finnish (FIN)
AF:
AC:
31
AN:
49072
Middle Eastern (MID)
AF:
AC:
29
AN:
5686
European-Non Finnish (NFE)
AF:
AC:
7679
AN:
1099036
Other (OTH)
AF:
AC:
366
AN:
59242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
513
1026
1540
2053
2566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00346 AC: 527AN: 152298Hom.: 4 Cov.: 33 AF XY: 0.00302 AC XY: 225AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
527
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
225
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
49
AN:
41582
American (AMR)
AF:
AC:
33
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5162
South Asian (SAS)
AF:
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
AC:
4
AN:
10614
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
421
AN:
68010
Other (OTH)
AF:
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
42
ExAC
AF:
AC:
362
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
not provided Benign:3
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
FLT4: BP4, BS1, BS2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Aug 15, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Capillary infantile hemangioma Pathogenic:1
Mar 01, 2002
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
Colorectal cancer Benign:1
Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Vest4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.